FDA gives Cytyc molecular testing boost for ThinPrep
This article was originally published in Clinica
Executive Summary
Putting more distance between itself and its competitors, Cytyc has gained US market approval to expand the labelling for its liquid-based ThinPrep Pap test in such a way as to facilitate the product's use in molecular testing.